DRUG NEWS

$3.95
Nursing2014
March 2012 
Volume 42  Number 3
Pages 16 - 16
 
  PDF Version Available!

ABSTRACT
The FDA has alerted pharmacists and healthcare providers about potential confusion involving two medications with similar trade names: Durezol (difluprednate ophthalmic emulsion) and Durasal (salicylic acid). Durezol is an FDA-approved topical ophthalmic corticosteroid used to treat postoperative inflammation and pain associated with ocular surgery. Durasal, a topical preparation used to treat common and plantar warts, doesn't have FDA approval. One serious injury was reported when a pharmacist dispensed Durasal instead of Durezol to a patient following ocular surgery.The FDA screens medication proprietary names for similarities upon approval. However, because Durasal isn't FDA-approved, it evaded this safety check.The FDA has asked the manufacturer to remove Durasal from the marketplace. In the meantime, continue to scrutinize medication packages and labels and report any potential for confusion to MedWatch Safety Information and Adverse Event Reporting Program at www.fda.gov/MedWatch/report.htm

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!


Cost:$3.95
1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Password


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.


Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.






jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles

What internal motivators drive RNs to pursue a BSN?
Nursing2014 , October 2014
Free access will expire on November 24, 2014.


Breast Cancer Risk Assessment in Primary Care
MCN, The American Journal of Maternal/Child Nursing, September/October 2014
Free access will expire on November 10, 2014.


Nurses spurring innovation
Nursing Management, October 2014
Free access will expire on November 10, 2014.


More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events